Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Hadar Zigdon-Giladi"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Medication-related osteonecrosis of the jaw is a serious complication that develops in oncologic patients treated with Zoledronic acid. Although used for over 30 years, the influence of Zoledronic acid on bone has been thoroughly investig
Externí odkaz:
https://doaj.org/article/e3dec52068c64b4d80fd96e190e7502c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Zoledronic acid (Zol) is a potent bisphosphonate that inhibits the differentiation of monocytes into osteoclasts. It is often used in combination with dexamethasone (Dex), a glucocorticoid that promotes the resolution of inflammation, to treat malign
Externí odkaz:
https://doaj.org/article/6a14a0dfa84048c589ecb2fa6d6d2555
Publikováno v:
Israel Journal of Health Policy Research, Vol 9, Iss 1, Pp 1-7 (2020)
Abstract Objectives Studies of emergency department (ED) visits for non-traumatic dental conditions (NTDCs) have been carried out in the USA and Canada. In Israel, there is a shortage of such studies. In the current retrospective study, we report on
Externí odkaz:
https://doaj.org/article/1ed2079393044589b1de54d94a11b12d
Publikováno v:
Cells, Vol 9, Iss 6, p 1325 (2020)
Vascularization is a prerequisite for bone formation. Endothelial progenitor cells (EPCs) stimulate bone formation by creating a vascular network. Moreover, EPCs secrete various bioactive molecules that may regulate bone formation. The aim of this re
Externí odkaz:
https://doaj.org/article/8a43ac90864246d7ba2f892fc3344044
Publikováno v:
Biomolecules, Vol 9, Iss 11, p 717 (2019)
Clinical trials have demonstrated the safety and efficacy of autologous endothelial progenitor cell (EPC) therapy in various diseases. Since EPCs’ functions are influenced by genetic, systemic and environmental factors, the therapeutic potential of
Externí odkaz:
https://doaj.org/article/4787b823fd974e3aba4e66f8ebf7dac5
Autor:
Ofri Doppelt-Flikshtain, Amin Younis, Tal Tamari, Ofir Ginesin, Talia Shentzer-Kutiel, David Nikomarov, Gil Bar-Sela, Benjamin R. Coyac, Yehuda G. Assaraf, Hadar Zigdon-Giladi
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1818
Background: Osteosarcoma (OS) mortality is attributed to lung metastases. Endothelial progenitor cells (EPCs) mediate the angiogenic switch in several cancers. The spatial proximity between EPCs and OS in the bone led to the hypothesis that EPCs-oste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d43f028844ce7a56730ba9c1895a0eb6
Publikováno v:
Journal of Oral Implantology.
Aims: To compare baseline residual ridge height using CBCT and panoramic radiographs. A secondary aim was to examine the magnitude of vertical bone gain 6-months following trans-crestal sinus augmentation and compare it between operators. Methods: Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::511f38fc86539207889a37c8a4c04e36
https://doi.org/10.1563/aaid-joi-d-21-00245
https://doi.org/10.1563/aaid-joi-d-21-00245
Publikováno v:
Clinical implant dentistry and related researchREFERENCES.
Previous studies focused on the influence of buccal mucosa thickness on peri-implant bone loss and inflammation, with inconclusive results. We observed substantially thicker palatal mucosal tissues at peri-implantitis sites. Therefore, we hypothesize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4835da0d48fa99e93114944af9c00aad
https://pubmed.ncbi.nlm.nih.gov/36537536
https://pubmed.ncbi.nlm.nih.gov/36537536
Autor:
Hadar Zigdon Giladi, Eran Gabay, Jacob Horwitz, Hiba Abu Hussein, Thabet Asbi, Eli E. Machtei
Publikováno v:
Clinical Implant Dentistry and Related Research. 23:726-734
BACKGROUND Chlorhexidine (CHX) is a broad-spectrum antimicrobial agent commonly used in medicine. Application of (CHX) during abutment connection reduced the bacterial load at the implant-abutment interface. We hypothesize this treatment may conseque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b330666b4af3051534de7c9a897c3261
https://doi.org/10.1111/cid.13041
https://doi.org/10.1111/cid.13041
Autor:
Chiho Ahn, Jacob Horwitz, Eli E. Machtei, Sahar Dowlatshahi, David M. Kim, Chia-Yu Chen, Hadar Zigdon-Giladi
Publikováno v:
Journal of Periodontology. 93:343-353
BACKGROUND The aim of this study was to examine osseous changes following lateral bone augmentation using a novel Ossix Volumax (OV) scaffold alone and compare it to combination therapy using freeze-dried bone allograft (FDBA) and resorbable collagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499d0a5c9218630b6624093f28d853fc
https://doi.org/10.1002/jper.21-0006
https://doi.org/10.1002/jper.21-0006